Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Novel sigma receptor antagonists combat cocaine-induced behavioral toxicity

Oct. 23, 2006

Desoxypeganine shows good pharmacokinetic profile in healthy volunteers

Oct. 11, 2006

Lofexidine studied for treatment of opiate withdrawal symptoms in phase III trial

Oct. 11, 2006

European approval for Suboxone for treatment of opioid dependence

Oct. 6, 2006

Alkermes developing oral products for treatment of addiction

Oct. 5, 2006

Champix approved in Europe

Oct. 2, 2006

PharmAthene awarded Department of Defense contract for Protexia development

Sep. 27, 2006

ArmaGen receives grant to develop first nerve gas antidote

Sep. 20, 2006

SBIR grant for Cleveland BioLabs' radioprotector research

Sep. 12, 2006

Aktiv-Dry awarded grant to develop inhalable nicotine vaccine

Sep. 4, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....